Affordable Access

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.

Type
Published Article
Journal
British journal of cancer
Publication Date
Jan 01, 1979
Volume
39
Issue
1
Pages
69–86
Identifiers
PMID: 365212
Source
Medline
License
Unknown

Abstract

Two hundred and fifty patients with acute myeloid leukaemia (AML) were randomized between 2 regimens of chemotherapy: TRAP and BARTS III. Overall, patients randomized to TRAP, which was the more intensive of the 2 regimens, fared slightly better (P = 0.06) than those on BARTS III. However, the improvement in survival associated with more intensive chemotherapy was substantial only for patients who had favourable prognostic features at presentation, such as a normal total leucocyte count, or absence of palpable liver, or, especially, age under 40. Indeed, for patients under 40, those allocated to the more intensive regimen (TRAP) lived considerably longer than those allocated to BARTS III (P less than 0.002) while for patients over 40 there was no material difference in survival between patients on the 2 protocols. It thus appears that intensive chemotherapy is likely to be more effective when favourable prognostic features are recorded.

Report this publication

Statistics

Seen <100 times